CHICAGO, Feb 3 (Reuters) - Edwards Lifesciences Corp (EW.N) (STJ.N) said on Tuesday fourth-quarter net earnings more than doubled on strong sales of its replacement heart valves. Net income rose to $38.1 million, or 66 cents a share, from $15.8 million, or 27 cents a share, a year ago.
